Christopher M. Andreoli, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Injuries, Penetrating | 12 | 2017 | 121 | 3.010 |
Why?
|
| Vitreoretinopathy, Proliferative | 3 | 2017 | 75 | 0.880 |
Why?
|
| Sclera | 3 | 2014 | 189 | 0.710 |
Why?
|
| Retinal Detachment | 4 | 2017 | 429 | 0.640 |
Why?
|
| Vitreoretinal Surgery | 1 | 2017 | 28 | 0.570 |
Why?
|
| Drug Substitution | 3 | 2015 | 292 | 0.520 |
Why?
|
| Wet Macular Degeneration | 2 | 2015 | 165 | 0.520 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2015 | 2057 | 0.500 |
Why?
|
| Visual Acuity | 13 | 2017 | 2714 | 0.500 |
Why?
|
| Eye Enucleation | 3 | 2012 | 128 | 0.500 |
Why?
|
| Ophthalmologic Surgical Procedures | 3 | 2012 | 354 | 0.440 |
Why?
|
| Macular Edema | 4 | 2016 | 387 | 0.360 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 215 | 0.340 |
Why?
|
| Eye Foreign Bodies | 1 | 2010 | 51 | 0.330 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 251 | 0.310 |
Why?
|
| Diabetic Retinopathy | 6 | 2016 | 1300 | 0.300 |
Why?
|
| Eye Diseases | 1 | 2014 | 660 | 0.300 |
Why?
|
| Cataract Extraction | 1 | 2011 | 464 | 0.270 |
Why?
|
| Endophthalmitis | 1 | 2009 | 263 | 0.260 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 2006 | 22 | 0.260 |
Why?
|
| Eye Infections, Bacterial | 1 | 2009 | 239 | 0.260 |
Why?
|
| Choroid Neoplasms | 1 | 2006 | 177 | 0.250 |
Why?
|
| Meningitis, Meningococcal | 1 | 2004 | 43 | 0.230 |
Why?
|
| Keratoconjunctivitis | 1 | 2004 | 41 | 0.230 |
Why?
|
| Burkitt Lymphoma | 1 | 2006 | 338 | 0.230 |
Why?
|
| Neisseria meningitidis | 1 | 2004 | 111 | 0.230 |
Why?
|
| Eye | 1 | 2007 | 711 | 0.220 |
Why?
|
| Exudates and Transudates | 3 | 2016 | 175 | 0.210 |
Why?
|
| Conjunctival Neoplasms | 1 | 2004 | 78 | 0.210 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 1422 | 0.200 |
Why?
|
| Sneezing | 1 | 2002 | 16 | 0.200 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 15 | 0.200 |
Why?
|
| Pupil Disorders | 1 | 2002 | 33 | 0.200 |
Why?
|
| Age Distribution | 4 | 2011 | 2869 | 0.190 |
Why?
|
| Blindness | 4 | 2009 | 585 | 0.180 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2015 | 661 | 0.180 |
Why?
|
| Diplopia | 1 | 2002 | 217 | 0.180 |
Why?
|
| Smoking | 1 | 2017 | 9077 | 0.170 |
Why?
|
| Vitrectomy | 2 | 2016 | 392 | 0.170 |
Why?
|
| Child, Preschool | 10 | 2017 | 42577 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2015 | 3511 | 0.160 |
Why?
|
| Neurilemmoma | 1 | 2004 | 522 | 0.150 |
Why?
|
| Retrospective Studies | 19 | 2017 | 81657 | 0.150 |
Why?
|
| Aged, 80 and over | 12 | 2017 | 59548 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2631 | 0.140 |
Why?
|
| Aged | 25 | 2017 | 171344 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2017 | 24299 | 0.130 |
Why?
|
| Scleral Buckling | 1 | 2016 | 95 | 0.130 |
Why?
|
| Massachusetts | 3 | 2017 | 8890 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 3738 | 0.130 |
Why?
|
| Sex Distribution | 2 | 2011 | 2274 | 0.120 |
Why?
|
| Infant | 7 | 2014 | 36459 | 0.120 |
Why?
|
| Adolescent | 13 | 2017 | 88902 | 0.120 |
Why?
|
| Middle Aged | 24 | 2017 | 223267 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15831 | 0.120 |
Why?
|
| Retinal Vein Occlusion | 1 | 2015 | 149 | 0.110 |
Why?
|
| Child | 10 | 2017 | 80670 | 0.110 |
Why?
|
| Young Adult | 9 | 2017 | 59939 | 0.110 |
Why?
|
| Trauma Severity Indices | 2 | 2013 | 479 | 0.110 |
Why?
|
| Male | 27 | 2017 | 364154 | 0.100 |
Why?
|
| Ocular Hypertension | 1 | 2014 | 211 | 0.100 |
Why?
|
| Retinal Diseases | 2 | 2009 | 709 | 0.100 |
Why?
|
| Adult | 19 | 2017 | 223305 | 0.100 |
Why?
|
| Time Factors | 4 | 2017 | 40149 | 0.090 |
Why?
|
| Refraction, Ocular | 1 | 2011 | 188 | 0.090 |
Why?
|
| Female | 23 | 2017 | 396532 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 4 | 2016 | 2954 | 0.090 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22248 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2016 | 12246 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 1814 | 0.080 |
Why?
|
| Eye Evisceration | 1 | 2009 | 22 | 0.080 |
Why?
|
| Humans | 34 | 2017 | 766812 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5389 | 0.070 |
Why?
|
| Glaucoma, Neovascular | 1 | 2007 | 37 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2015 | 6329 | 0.070 |
Why?
|
| Incidence | 3 | 2017 | 21527 | 0.070 |
Why?
|
| Recurrence | 2 | 2017 | 8507 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 2392 | 0.070 |
Why?
|
| Exophthalmos | 1 | 2008 | 100 | 0.070 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2008 | 252 | 0.060 |
Why?
|
| Lipids | 1 | 2016 | 3322 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 9101 | 0.060 |
Why?
|
| Body Fluids | 1 | 2006 | 321 | 0.060 |
Why?
|
| Retinal Neovascularization | 1 | 2007 | 287 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2012 | 1090 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5306 | 0.060 |
Why?
|
| Choroidal Neovascularization | 1 | 2007 | 364 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 2228 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 39312 | 0.060 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 386 | 0.050 |
Why?
|
| Ceftriaxone | 1 | 2004 | 176 | 0.050 |
Why?
|
| Wnt Proteins | 1 | 2007 | 722 | 0.050 |
Why?
|
| S100 Proteins | 1 | 2004 | 215 | 0.050 |
Why?
|
| Deafness | 1 | 2007 | 460 | 0.050 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 71 | 0.050 |
Why?
|
| Risk Factors | 6 | 2017 | 74889 | 0.050 |
Why?
|
| Retinopathy of Prematurity | 1 | 2007 | 450 | 0.050 |
Why?
|
| Intravitreal Injections | 2 | 2015 | 402 | 0.050 |
Why?
|
| Limbus Corneae | 1 | 2004 | 144 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 13489 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1838 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2014 | 5990 | 0.050 |
Why?
|
| Retinal Artery Occlusion | 1 | 2002 | 83 | 0.050 |
Why?
|
| Phacoemulsification | 1 | 2003 | 151 | 0.050 |
Why?
|
| Meckel Diverticulum | 1 | 2001 | 32 | 0.050 |
Why?
|
| Cataract | 1 | 2007 | 837 | 0.050 |
Why?
|
| Penicillins | 1 | 2004 | 404 | 0.050 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2002 | 87 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 2006 | 962 | 0.050 |
Why?
|
| Fluorescein Angiography | 1 | 2006 | 1086 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 234 | 0.050 |
Why?
|
| Optic Neuritis | 1 | 2002 | 173 | 0.040 |
Why?
|
| Injections | 1 | 2003 | 839 | 0.040 |
Why?
|
| Macular Degeneration | 1 | 2007 | 1015 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 6306 | 0.040 |
Why?
|
| Optic Nerve Diseases | 1 | 2003 | 342 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2009 | 7475 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 8540 | 0.040 |
Why?
|
| Retina | 1 | 2009 | 2660 | 0.040 |
Why?
|
| Strabismus | 1 | 2002 | 320 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15425 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 20146 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2003 | 1005 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2016 | 208 | 0.030 |
Why?
|
| Macula Lutea | 1 | 2016 | 180 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2016 | 65286 | 0.030 |
Why?
|
| Hyphema | 1 | 2014 | 26 | 0.030 |
Why?
|
| Follicular Phase | 1 | 1994 | 143 | 0.030 |
Why?
|
| Luteal Phase | 1 | 1994 | 138 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 5098 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2004 | 12985 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2014 | 387 | 0.020 |
Why?
|
| Vision Tests | 1 | 2011 | 160 | 0.020 |
Why?
|
| Observer Variation | 1 | 2016 | 2614 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2016 | 8533 | 0.020 |
Why?
|
| Prognosis | 5 | 2014 | 29959 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2015 | 2659 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2014 | 1304 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 26387 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 1989 | 269 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 4618 | 0.020 |
Why?
|
| Orbital Neoplasms | 1 | 2008 | 223 | 0.020 |
Why?
|
| Photography | 1 | 2008 | 536 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 23618 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9661 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6514 | 0.010 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2003 | 192 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6422 | 0.010 |
Why?
|
| Temporal Arteries | 1 | 2002 | 155 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 2003 | 277 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 13036 | 0.010 |
Why?
|
| Arteritis | 1 | 2002 | 160 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2002 | 568 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2978 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2003 | 36570 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9358 | 0.010 |
Why?
|
| Intestinal Obstruction | 1 | 2001 | 433 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 3446 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18397 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12808 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 1994 | 21162 | 0.010 |
Why?
|
| Health Personnel | 1 | 2008 | 3384 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 18076 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 7240 | 0.010 |
Why?
|
| Axilla | 1 | 1994 | 622 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 54872 | 0.010 |
Why?
|
| Biopsy | 1 | 2002 | 6779 | 0.010 |
Why?
|
| Premenopause | 1 | 1994 | 1039 | 0.010 |
Why?
|
| United States | 1 | 2016 | 72945 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 2002 | 12430 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1994 | 3468 | 0.000 |
Why?
|
| Survival Rate | 1 | 1994 | 12826 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1994 | 12536 | 0.000 |
Why?
|
| Radiography | 1 | 1989 | 6968 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20710 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1989 | 12064 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1994 | 9407 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1994 | 13644 | 0.000 |
Why?
|